Kelun Biotech's sac-TMT plus Merck's Keytruda shows significant progress in late-stage lung cancer trial. Read more here.

Merck's drug is an antiretroviral treatment, a combination of medicines used to stop the reproduction of the virus.

The FDA's Fast Track program develops and accelerates therapies for conditions with unmet medical needs, Merck said. Cladribine falls under the Orphan Drug Designation for patients of rare diseases, ...

As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles (GAAP) are increasingly recognized as meaningful signals of ...

A new daily pill reduced bad cholesterol by 60% in a groundbreaking study of 303 adults with a genetic condition, offering hope for heart disease prevention.

Merck and Elevance Health stocks are top dividend growth picks with solid yields and attractive valuations. Click here to ...

Valo Health, Inc. ("Valo"), a company pioneering the use of human data and AI to accelerate drug discovery and development, today announced a strategic collaboration with Merck KGaA, Darmstadt, ...

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...

Over the past two years, Merck ( MRK 0.19%) has faced several challenges, resulting in a decline in the company's share price ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the company, through a subsidiary Prometheus BioSciences, has reached an agreement with Dr. Falk Pharma GmbH to ...

The once-daily oral medication, which targets the PCSK9 protein in the liver, has shown the ability to reduce LDL cholesterol levels by nearly 60 percent in clinical trials, according to results ...